14133-63-2

Basic information

• Product Name: METHYL 2,3-O-ISOPROPYLIDENE-ALPHA-L-RHAMNOPYRANOSE
• Synonyms: METHYL 2,3-O-ISOPROPYLIDENE-ALPHA-L-RHAMNOPYRANOSE;Methyl 2,3-O-isopropylidene-a-L-rhamnopyranoside;Methyl 2,3-O-isopropylidene-alpha-L-rhamnopyranoside
• CAS NO: 14133-63-2
• Molecular Formula: C₁₀H₁₈O₅
• Molecular Weight: 218.24692
• Mol File: 14133-63-2.mol
• Article Data: 44

Chemical Properties

• Appearance: /
• CAS DataBase Reference: METHYL 2,3-O-ISOPROPYLIDENE-ALPHA-L-RHAMNOPYRANOSE(CAS DataBase Reference)
• NIST Chemistry Reference: METHYL 2,3-O-ISOPROPYLIDENE-ALPHA-L-RHAMNOPYRANOSE(14133-63-2)
• EPA Substance Registry System: METHYL 2,3-O-ISOPROPYLIDENE-ALPHA-L-RHAMNOPYRANOSE(14133-63-2)

Safety Data

• Hazardous Substances Data: 14133-63-2(Hazardous Substances Data)

Usage

General Description

Methyl 2,3-O-Isopropylidene-alpha-L-rhamnopyranose is a chemical compound used in organic synthesis and carbohydrate chemistry. It is a derivative of the sugar L-rhamnose, which is commonly found in plants and bacteria. METHYL 2,3-O-ISOPROPYLIDENE-ALPHA-L-RHAMNOPYRANOSE is used as a building block in the synthesis of various pharmaceuticals, natural products, and bioactive compounds. Its unique structure and reactivity make it valuable for the formation of complex molecules in chemical research and drug discovery. Additionally, its ability to protect the hydroxyl group of the sugar molecule makes it particularly useful in the formation of glycosidic linkages and sugar derivatives.

Upstream product

• 72959-83-2 methyl-[O²,O³-isopropylidene-O⁴-(toluene-4-sulfonyl)-α-L-rhamnopyranoside] 
• 67-56-1 methanol 
• 3615-41-6 L-Rhamnose 
• 67-64-1 acetone 
• 75754-53-9 2-Oxo-propionic acid (3aR,4R,6S,7S,7aR)-4-methoxy-2,2,6-trimethyl-tetrahydro-[1,3]dioxolo[4,5-c]pyran-7-yl ester 
• 6014-42-2 L-rhamnose 
• 77-76-9 2,2-dimethoxy-propane 
• 51103-66-3 methyl 6-O-(p-tolylsulfonyl)-α-D-mannopyranoside 
• 116-11-0 2-Methoxypropene 
• 5155-43-1 methyl 6-deoxy-α-D-glucopyranoside 
• 14133-63-2 methyl 6-deoxy-2,3-O-isopropylidene-α-D-glucopyranoside 
• 42214-02-8 methyl 6-deoxy-2,3-O-isopropylidene-α-L-lyxo-hexopyranosid-4-ulose 
• 530-26-7 D-Mannose 
• 13035-60-4 methyl 2,3:4,6-di-O-isopropylidene-α-D-mannopyranoside 

Downstream Products

• 850647-97-1 methyl 2,3-di-O-benzyl-4,6-O-(p-methoxybenzylidene)-7-O-(t-butyldiphenylsilyl)-D-glycero-β-D-manno-heptopyranosyl-(1->4)-2,3-O-isopropylidene-α-L-rhamnopyranoside 
• 135216-53-4 methyl 6-deoxy-2,3-O-isopropylidene-4-O-<(p-nitrophenyl)sulfonyl>-α-D-mannopyranoside 
• 10515-99-8 methyl 6-deoxy-2,3-O-isopropylidene-4-O-(p-tolylsulfonyl)-α-D-mannopyranoside 
• 86447-92-9 methyl 4-O-benzyl-6-deoxy-2,3-O-isopropylidene-α-D-mannopyranoside 
• 111373-93-4 methyl 2,3-O-isopropylidene-4-O-(p-bromobenzyl)-α-L-rhamnopyranoside 
• 110224-84-5 Acetic acid (2R,3S,4S,5R)-3,5-bis-benzyloxy-2-benzyloxymethyl-6-((3aR,4R,6S,7S,7aR)-4-methoxy-2,2,6-trimethyl-tetrahydro-[1,3]dioxolo[4,5-c]pyran-7-yloxy)-tetrahydro-pyran-4-yl ester 

Relevant articles and documents

Improved Synthesis for Modular Ascarosides Uncovers Biological Activity

A versatile synthesis of modular ascarosides, a family of signaling molecules from Caenorhabditis elegans and other nematodes, via hydrogenolysis of a cyclic sulfate derived from methyl-α-l-rhamnopyranoside is reported. The route enables selective introdu

BIARYL AMIDES WITH MODIFIED SUGAR GROUPS FOR TREATMENT OF DISEASES ASSOCIATED WITH HEAT SHOCK PROTEIN PATHWAY

Provided are biaryl amides and coumarin-based compounds with modified sugar groups for treatment of diseases associated with heat shock protein pathway. The compounds having the following formulas, wherein variables are as defined herein. Formulae (I), (II), (III), (IV), and (V), Pharmaceutical compositions of the compounds are also provided. These biaryl amides and coumarin-based derivatives with modified sugar groups are useful for treatment and prevention of diseases and disorders, including neurological disorders, such as neurodegenerative diseases and nerve damaging disorders, for example, diabetic peripheral neuropathy.

Synthetic glycoconjugates characterize the fine specificity of: Brucella A and M monoclonal antibodies

The dominant cell wall antigen of Brucella bacteria is the O-polysaccharide component of the smooth lipopolysaccharide. Infection by various Brucella biovars causes abortions and infertility in a wide range of domestic and wild animals and debilitating disease in humans. Diagnosis relies on the detection of antibodies to the A and M antigens expressed in the O-polysaccharide. This molecule is a homopolymer of the rare monosaccharide, 4-formamido-4,6-dideoxy-d-mannopyranose (Rha4NFo). The A epitope is created by a uniform α1,2 linked internal polymeric sequence capped by a distinct tetrasaccharide sequence defining the M antigen. Unique oligosaccharides only available by chemical synthesis and conjugated via reducing and non-reducing residues to bovine serum albumin have revealed the structural basis of the fine specificity that allows the discrimination of these closely related A and M epitopes. All three M specific monoclonal antibodies (mAbs) are inferred to possess groove type binding sites open at each end, and recognize an α1,3 linked Rha4NFo disaccharide as a part of a trisaccharide epitope, which in two mAbs includes the terminal Rha4NFo residue. The binding site of one of these antibodies is sufficiently large to engage up to six Rha4NFo residues and involves weak recognition of α1,2 linked Rha4NFo residues. The third mAb binds an internal trisaccharide epitope of the M tetrasaccharide. Two A specific mAbs also possess groove type binding sites that accommodate six and four α1,2 linked Rha4NFo residues.